Growing evidence implicates inflammation as a central mechanism in AD pathophysiology, serving not only as a consequence of Aβ and tau pathology but also as an active driver of neurodegeneration and cognitive impairment. The gene discussed is MAPT; the disease is Alzheimer disease.